0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover346.26%IV-68.79%PremiumMay 16, 2025Expiry Date5.51Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9841Delta0.0078Gamma1.44Leverage Ratio-0.0081Theta0.0008Rho1.42Eff Leverage0.0006Vega
Rocket Pharmaceuticals Stock Discussion
After the successful gene therapy, which was sponsored by Rocket Pharmaceuticals, Eisa was able to have a further heart procedure to fix a separate condition.
After the successful gene therapy, which was sponsored by Rocket Pharmaceuticals, Eisa was able to have a further heart procedure to fix a separate condition.
Gene therapy trial saves boy, 4, from ‘death sentence’
Socket Mobile's New $1,900 iOS Scanner Targets Massive $27B Enterprise Market
#tradingGuruAssemble
#pleaseandthankyou
No comment yet